For citations:
Kolganova M.A., Beketov E.E., Pisarev V.V., Ivanov A.V., Vasiliev S.V., Shokhin I.E. A Double-blind Randomized Comparative Phase I Study to Assess Biosimilarity and Immunogenicity of "Trastuzumab" (LLC "Mabscale", Russia) and Herceptin® (F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Volunteers. Drug development & registration. 2023;12(3):240-249. (In Russ.) https://doi.org/10.33380/2305-2066-2023-12-3-240-249
Email this article 